Goldman Sachs Group Inc Moon Lake Immunotherapeutics Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,495,831 shares of MLTX stock, worth $76.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,495,831

Previous 1,251,747 19.5%

Holding current value

$76.5 Million

Previous $55 Million 37.03%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.15 - $55.4 $9.8 Million - $13.5 Million	244,084 Added 19.5%	1,495,831 $75.4 Million
Q2 2024 Aug 13, 2024	BUY	$38.43 - $48.6 $42 Million - $53.1 Million	1,093,587 Added 691.44%	1,251,747 $55 Million
Q1 2024 May 15, 2024	BUY	$43.78 - $63.86 $307,598 - $448,680	7,026 Added 4.65%	158,160 $7.94 Million
Q4 2023 Feb 13, 2024	BUY	$36.35 - $63.02 $1.98 Million - $3.43 Million	54,447 Added 56.31%	151,134 $9.13 Million
Q3 2023 May 14, 2024	SELL	$48.35 - $61.26 $2.63 Million - $3.34 Million	-54,447 Reduced 36.03%	96,687 $5.51 Million
Q3 2023 Nov 14, 2023	BUY	$48.35 - $61.26 $347,443 - $440,214	7,186 Added 8.03%	96,687 $5.51 Million
Q2 2023 May 14, 2024	BUY	$19.01 - $51.79 $1.51 Million - $4.11 Million	79,391 Added 785.27%	89,501 $4.56 Million
Q2 2023 Aug 14, 2023	BUY	$19.01 - $51.79 $1.7 Million - $4.64 Million	89,501 New	89,501 $4.56 Million
Q4 2022 May 14, 2024	SELL	$7.05 - $10.5 $705 - $1,050	-100 Reduced 0.98%	10,110 $106,000
Q4 2022 Feb 13, 2023	SELL	$7.05 - $10.5 $705 - $1,050	-100 Reduced 0.98%	10,110 $106,000
Q3 2022 May 14, 2024	SELL	$5.25 - $9.27 $8,268 - $14,600	-1,575 Reduced 13.36%	10,210 $79,000
Q3 2022 Nov 10, 2022	SELL	$5.25 - $9.27 $8,268 - $14,600	-1,575 Reduced 13.36%	10,210 $0
Q2 2022 May 14, 2024	SELL	$4.69 - $13.25 $653,546 - $1.85 Million	-139,349 Reduced 92.2%	11,785 $62,000
Q2 2022 Aug 15, 2022	BUY	$4.69 - $13.25 $55,271 - $156,151	11,785 New	11,785 $62,000

Others Institutions Holding MLTX

# of Institutions

124

Shares Held

58.2M

Call Options Held

52.2K

Put Options Held

38K

View Full List

About MoonLake Immunotherapeutics

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $1.89B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

More about MLTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Moon Lake Immunotherapeutics Transaction History